Literature DB >> 25805159

[Primary renal angiosarcoma. Uncommon manifestation of a rare malignancy].

J Rüb1, S Bauer, J Pastor, J Noldus, R J Palisaar.   

Abstract

This article reports a case of primary renal angiosarcoma, a very rare and aggressive malignancy, in a 59-year-old male patient. The mean overall survival time is limited to a few months if the diagnosis is made when clinical symptoms are present but chances of a cure can be increased with surgical resection of smaller incidental findings. Due to the lack of a standard therapy, systemic treatment is based on the therapy of other soft tissue sarcomas. The role of adjuvant medical treatment particularly in angiosarcoma remains poorly studied but using a doxorubicin-based chemotherapy regimen, a survival benefit can be achieved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25805159     DOI: 10.1007/s00120-015-3809-0

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  7 in total

1.  Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial.

Authors:  Winette T A van der Graaf; Jean-Yves Blay; Sant P Chawla; Dong-Wan Kim; Binh Bui-Nguyen; Paolo G Casali; Patrick Schöffski; Massimo Aglietta; Arthur P Staddon; Yasuo Beppu; Axel Le Cesne; Hans Gelderblom; Ian R Judson; Nobuhito Araki; Monia Ouali; Sandrine Marreaud; Rachel Hodge; Mohammed R Dewji; Corneel Coens; George D Demetri; Christopher D Fletcher; Angelo Paolo Dei Tos; Peter Hohenberger
Journal:  Lancet       Date:  2012-05-16       Impact factor: 79.321

2.  [Adjuvant chemotherapy for soft tissue sarcoma? a clear no - well - yes-ish].

Authors:  A Abendroth; S Bauer
Journal:  Dtsch Med Wochenschr       Date:  2013-10-01       Impact factor: 0.628

Review 3.  Primary renal angiosarcoma: a rare malignancy. A case report and review of the literature.

Authors:  Lorenzo Leggio; Giovanni Addolorato; Ludovico Abenavoli; Anna Ferrulli; Christina D'Angelo; Antonio Mirijello; Luisa Vonghia; Giovanni Schinzari; Vincenzo Arena; Luca Perrone; Franco Citterio; Lorenzo Bonomo; Gian Ludovico Rapaccini; Arnaldo Capelli; Carlo Barone; Giovanni Gasbarrini
Journal:  Urol Oncol       Date:  2006 Jul-Aug       Impact factor: 3.498

4.  Long-term responders and survivors on pazopanib for advanced soft tissue sarcomas: subanalysis of two European Organisation for Research and Treatment of Cancer (EORTC) clinical trials 62043 and 62072.

Authors:  B Kasper; S Sleijfer; S Litière; S Marreaud; J Verweij; R A Hodge; S Bauer; J M Kerst; W T A van der Graaf
Journal:  Ann Oncol       Date:  2014-02-06       Impact factor: 32.976

5.  Primary renal angiosarcoma: Case report and literature review.

Authors:  Ahmed Chaabouni; Nouri Rebai; Kamel Chabchoub; Mohamed Fourati; Mahdi Bouacida; Mourad Hadj Slimen; Ali Bahloul; Mohamed Nabil Mhiri
Journal:  Can Urol Assoc J       Date:  2013 May-Jun       Impact factor: 1.862

Review 6.  Angiosarcoma. A report of 67 patients and a review of the literature.

Authors:  R J Mark; J C Poen; L M Tran; Y S Fu; G F Juillard
Journal:  Cancer       Date:  1996-06-01       Impact factor: 6.860

7.  Development of hepatic angiosarcoma in man induced by vinyl chloride, thorotrast, and arsenic. Comparison with cases of unknown etiology.

Authors:  H Popper; L B Thomas; N C Telles; H Falk; I J Selikoff
Journal:  Am J Pathol       Date:  1978-08       Impact factor: 4.307

  7 in total
  3 in total

1.  Primary Angiosarcoma of the Kidney: Case Report and Comprehensive Literature Review.

Authors:  Andrea Boni; Giovanni Cochetti; Angelo Sidoni; Guido Bellezza; Emanuele Lepri; Andrea De Giglio; Morena Turco; Jacopo Adolfo Rossi De Vermandois; Michele Del Zingaro; Roberto Cirocchi; Ettore Mearini
Journal:  Open Med (Wars)       Date:  2019-07-31

Review 2.  Primary vascular tumours of the kidney.

Authors:  Ayo O Omiyale
Journal:  World J Clin Oncol       Date:  2021-12-24

Review 3.  Clinicopathological features of primary angiosarcoma of the kidney: a review of 62 cases.

Authors:  Ayodeji Oluwarotimi Omiyale
Journal:  Transl Androl Urol       Date:  2015-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.